查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589666

有效性测试市场：按测试类型、应用划分 - 2025-2030 年全球预测

Efficacy Testing Market by Test Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing), Application (Consumer Product, Cosmetics & Personal Care Product, Medical Device) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药效测试市场规模为3.067亿美元，预计2024年将达到3.2733亿美元，复合年增长率为6.82%，预计到2030年将达到4.8676亿美元。

功效试验在评估和检验产品、服务和介入措施的性能并确保它们在现实场景中达到预期结果和效益方面发挥关键作用。该领域涵盖製药、农业、个人护理和技术等多个领域，了解功效对于市场接受度和监管合规性至关重要。功效测试的必要性在于其能够提供经验资料来支援产品声明、增强消费者信心并帮助竞争市场定位。应用范围包括先驱性研究、临床试验、消费者测试和产品优化，最终用途包括製造商、研发专业人员和监管机构。影响该市场的关键成长要素包括提高消费者寻求透明度的素养、严格的法律规范以及人工智慧和资料分析等最尖端科技的普及，以提高测试准确性。最新的潜在机会包括利用人工智慧来简化资料分析流程，以及采用区块链来增强测试结果的资料完整性。公司可以透过投资以技术为重点的研发、培养与高科技公司的伙伴关係以及瞄准智慧自动化流程来抓住这些机会。然而，市场面临挑战，包括与严格测试流程相关的高成本、不断变化的监管标准以及对技术采用的潜在阻力。为了在这种环境中竞争，必须透过具有成本效益的创新和强大的相关人员参与来克服这些障碍。需要创新的领域包括开发具有成本效益的测试模型、整合体外和电脑方法相结合的混合测试方法，以及探索生物资讯学以提高预测分析能力。用于了解消费行为的复杂资料分析和扩展的虚拟测试环境可实现高效、快速的调查方法。市场的动态本质要求不断适应，企业必须在创新和监管之间取得平衡，同时满足消费者的期望。这种积极主动的方法可以促进永续成长和復原力，推动企业在竞争激烈的市场中前进。

主要市场统计
基准年[2023] 3.067 亿美元
预测年份 [2024] 3.2733亿美元
预测年份 [2030] 4.8676 亿美元
复合年增长率（%） 6.82%

市场动态：揭示快速发展的功效测试市场的关键市场洞察

功效测试市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 对产品污染控制高度关注
    • 增加製药业研发活动的投资
    • 扩大抗菌功效测试在各种医疗设备中的使用
  • 市场限制因素
    • 各种功效测试和试验相关的高成本
  • 市场机会
    • 政府政策和措施旨在确保新产品的安全性和稳定性，主要集中在製药和医疗领域。
    • 持续开发先进功效测试
  • 市场挑战
    • 功效试验核准流程复杂且耗时

波特五力：驾驭有效性测试市场的策略工具

波特的五力架构是了解有效性测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药效测试市场的外部影响

外部宏观环境因素在塑造药效检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解有效性测试市场的竞争状况

有效性测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，使他们的公司能够应对日益激烈的竞争。

FPNV定位矩阵效能测试市场供应商绩效评估

FPNV定位矩阵是功效测试市场中评估供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了有效性测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，有效性测试市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 注重产品污染控制
      • 增加製药业研发活动的投资
      • 扩大抗菌功效检测在各类医疗设备的应用
    • 抑制因素
      • 各种功效测试和试验成本高
    • 机会
      • 主要针对製药和医疗领域的新产品安全性和稳定性的政府政策和倡议
      • 持续开发先进的功效测试
    • 任务
      • 功效试验的核准流程复杂且耗时
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按测试类型分類的有效性测试市场

  • 抗菌/防腐功效测试
    • 快速测试方法
    • 常规测试方法
  • 消毒剂功效测试
    • 表面测试方法
    • 悬浮试验方法

第七章功效测试市场：依应用分类

  • 消费品
  • 化妆品和个人保健产品
  • 医疗设备
  • 药品製造

第8章：美洲功效测试市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太有效性测试市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲药效检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Analytical Ltd
  • Accugen Laboratories, Inc.
  • Betco
  • Bioscience Laboratories, Inc.
  • Blutest Laboratories Limited
  • Cantel Medical Corporation
  • Charles River Laboratories International, Inc.
  • Diversey, Inc.
  • Ecolab Inc.
  • Eurofins Scientific SE
  • Intertek Group PLC
  • Nelson Laboratories, LLC
  • Pacific Biolabs Inc
  • Q Laboratories
  • SGS SA
Product Code: MRR-4F4C362635B7

The Efficacy Testing Market was valued at USD 306.70 million in 2023, expected to reach USD 327.33 million in 2024, and is projected to grow at a CAGR of 6.82%, to USD 486.76 million by 2030.

Efficacy testing plays a crucial role in evaluating and validating the performance of products, services, or interventions, ensuring they meet the intended results and benefits in real-world scenarios. This encompasses various sectors such as pharmaceuticals, agriculture, personal care, and technology, where understanding efficacy is vital for market acceptance and regulatory compliance. The necessity of efficacy testing lies in its ability to provide empirical data supporting product claims, enhancing consumer trust and aiding in competitive market positioning. Its application spans pilot studies, clinical trials, consumer testing, and product optimization, with end-use users ranging from manufacturers, R&D specialists, to regulatory bodies. Key growth factors influencing this market include increased consumer literacy demanding transparency, stringent regulatory frameworks, and the proliferation of cutting-edge technologies such as AI and data analytics enhancing testing precision. The latest potential opportunities include leveraging AI to streamline data analysis processes and adopting blockchain for enhanced data integrity in test results. Businesses can seize these opportunities by investing in technology-focused R&D, fostering partnerships with tech firms, and targeting intelligent automation processes. However, the market faces challenges such as high costs associated with rigorous testing processes, evolving regulatory standards, and potential resistance to technological adoption. Competing in this landscape requires overcoming these hurdles through cost-effective innovation and robust stakeholder engagement. Areas ripe for innovation include the development of cost-efficient testing models, integration of hybrid testing methodologies combining in vitro and in silico approaches, and exploration of bioinformatics to enhance predictive analysis capabilities. Understanding consumer behavior through sophisticated data analytics and expanding virtual testing environments enable efficient and rapid efficacy testing methodologies. The market's dynamic nature demands continuous adaptation, with companies needing to balance innovation and regulation while addressing consumer expectations. This proactive approach fosters sustainable growth and resilience, propelling businesses forward in a competitive marketplace.

KEY MARKET STATISTICS
Base Year [2023] USD 306.70 million
Estimated Year [2024] USD 327.33 million
Forecast Year [2030] USD 486.76 million
CAGR (%) 6.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Efficacy Testing Market

The Efficacy Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High focus on contamination control in products
    • Increasing investments for the research and development activities in the pharmaceutical sector
    • Growing applications of antimicrobial efficacy testing in various medical devices
  • Market Restraints
    • High cost involved in different efficacy testing and trials
  • Market Opportunities
    • Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
    • Ongoing development of advanced efficacy testing
  • Market Challenges
    • Complex and time-consuming process for approval for efficacy testing

Porter's Five Forces: A Strategic Tool for Navigating the Efficacy Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Efficacy Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Efficacy Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Efficacy Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Efficacy Testing Market

A detailed market share analysis in the Efficacy Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Efficacy Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Efficacy Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Efficacy Testing Market

A strategic analysis of the Efficacy Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Efficacy Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Analytical Ltd, Accugen Laboratories, Inc., Betco, Bioscience Laboratories, Inc., Blutest Laboratories Limited, Cantel Medical Corporation, Charles River Laboratories International, Inc., Diversey, Inc., Ecolab Inc., Eurofins Scientific SE, Intertek Group PLC, Nelson Laboratories, LLC, Pacific Biolabs Inc, Q Laboratories, and SGS S.A..

Market Segmentation & Coverage

This research report categorizes the Efficacy Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing. The Antimicrobial/Preservative Efficacy Testing is further studied across Rapid Test Method and Traditional Test Method. The Disinfectant Efficacy Testing is further studied across Surface Test Method and Suspension Test Method.
  • Based on Application, market is studied across Consumer Product, Cosmetics & Personal Care Product, Medical Device, and Pharmaceutical Manufacturing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High focus on contamination control in products
      • 5.1.1.2. Increasing investments for the research and development activities in the pharmaceutical sector
      • 5.1.1.3. Growing applications of antimicrobial efficacy testing in various medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in different efficacy testing and trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
      • 5.1.3.2. Ongoing development of advanced efficacy testing
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and time-consuming process for approval for efficacy testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Efficacy Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Antimicrobial/Preservative Efficacy Testing
    • 6.2.1. Rapid Test Method
    • 6.2.2. Traditional Test Method
  • 6.3. Disinfectant Efficacy Testing
    • 6.3.1. Surface Test Method
    • 6.3.2. Suspension Test Method

7. Efficacy Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Consumer Product
  • 7.3. Cosmetics & Personal Care Product
  • 7.4. Medical Device
  • 7.5. Pharmaceutical Manufacturing

8. Americas Efficacy Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Efficacy Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Efficacy Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Analytical Ltd
  • 2. Accugen Laboratories, Inc.
  • 3. Betco
  • 4. Bioscience Laboratories, Inc.
  • 5. Blutest Laboratories Limited
  • 6. Cantel Medical Corporation
  • 7. Charles River Laboratories International, Inc.
  • 8. Diversey, Inc.
  • 9. Ecolab Inc.
  • 10. Eurofins Scientific SE
  • 11. Intertek Group PLC
  • 12. Nelson Laboratories, LLC
  • 13. Pacific Biolabs Inc
  • 14. Q Laboratories
  • 15. SGS S.A.

LIST OF FIGURES

  • FIGURE 1. EFFICACY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. EFFICACY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EFFICACY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EFFICACY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EFFICACY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EFFICACY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EFFICACY TESTING MARKET SIZE, BY RAPID TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EFFICACY TESTING MARKET SIZE, BY TRADITIONAL TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EFFICACY TESTING MARKET SIZE, BY SURFACE TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EFFICACY TESTING MARKET SIZE, BY SUSPENSION TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EFFICACY TESTING MARKET SIZE, BY CONSUMER PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EFFICACY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EFFICACY TESTING MARKET SIZE, BY MEDICAL DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EFFICACY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2023